Specifically, it acts as a single peptide that simultaneously activates three receptors involved in metabolic regulation: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR)
The most common adverse events occurring in 5% of participants were nausea, diarrhea, constipation, injection site reaction, dosing error, vomiting, and dizziness in the Taltz and Zepbound concomitant treatment arm, and injection site reaction, dosing error, and nasopharyngitis in the Taltz monotherapy arm
These effects of IGF-1 LR3 ultimately lead to a reduced insulin requirement by up to 10% in order to maintain blood sugar levels [10, 11, 12]
The point is to let your GLP-1 and GIP receptors begin responding to exogenous stimulation at a pace that does not overwhelm them
However, its important to note that the effectiveness of these supplements is debated, and individual results may vary
& Yamagishi, S
.png)
